GRFS Grifols SA ADRs

Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses. This is an ADR of a company whose stock trades outside of the U.S. as the symbol SM:GRF.P .

$6.60  -0.32 (-4.56%)
As of 09/27/2022 15:59:42 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  Spain
Country of incorporation:  Spain
IPO date:  06/02/2011
Outstanding shares:  261,425,000
Average volume:  1,124,717
Market cap:   $1,837,817,750
Current dividend yield:  7.05%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      B8K7T65
Valuation   (See tab for details)
PE ratio:   92.44
PB ratio:   1.56
PS ratio:   0.34
Return on equity:   12.91%
Net income %:   12.83%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy